147 related articles for article (PubMed ID: 3803679)
1. [Variability of enzyme activity and urinary orotic acid in ornithine transcarbamylase deficient spf/+ heterozygotic mice].
Qureshi IA; Letarte J; Lebel S; Ouellet R
Diabete Metab; 1986 Oct; 12(5):250-5. PubMed ID: 3803679
[TBL] [Abstract][Full Text] [Related]
2. Transient hyperammonemia during aging in ornithine transcarbamylase-deficient, sparse-fur mice.
Gushiken T; Yoshimura N; Saheki T
Biochem Int; 1985 Nov; 11(5):637-43. PubMed ID: 4091843
[TBL] [Abstract][Full Text] [Related]
3. The effects of various inhibitors on the regulation of orotic acid excretion in sparse-fur mutant mice (spf/Y) deficient in ornithine transcarbamylase.
Nelson J; Qureshi IA; Vasudevan S; Sarma DS
Chem Biol Interact; 1993 Oct; 89(1):35-47. PubMed ID: 8221965
[TBL] [Abstract][Full Text] [Related]
4. Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women.
Hauser ER; Finkelstein JE; Valle D; Brusilow SW
N Engl J Med; 1990 Jun; 322(23):1641-5. PubMed ID: 2342523
[TBL] [Abstract][Full Text] [Related]
5. The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency.
Maestri NE; Lord C; Glynn M; Bale A; Brusilow SW
Medicine (Baltimore); 1998 Nov; 77(6):389-97. PubMed ID: 9854602
[TBL] [Abstract][Full Text] [Related]
6. Study of enzyme defect in a case of ornithine transcarbamylase deficiency.
Qureshi IA; Letarte J; Quellet R
Diabete Metab; 1978 Dec; 4(4):239-41. PubMed ID: 729890
[TBL] [Abstract][Full Text] [Related]
7. Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors.
Moscioni D; Morizono H; McCarter RJ; Stern A; Cabrera-Luque J; Hoang A; Sanmiguel J; Wu D; Bell P; Gao GP; Raper SE; Wilson JM; Batshaw ML
Mol Ther; 2006 Jul; 14(1):25-33. PubMed ID: 16677864
[TBL] [Abstract][Full Text] [Related]
8. Importance of ornithine transcarbamylase (OTC) deficiency in small intestine for urinary orotic acid excretion: analysis of OTC-deficient spf-ash mice with OTC transgene.
Saheki T; Mori K; Kobayashi K; Horiuchi M; Shige T; Obara T; Suzuki S; Mori M; Yamamura K
Biochim Biophys Acta; 1995 Jan; 1270(1):87-93. PubMed ID: 7827141
[TBL] [Abstract][Full Text] [Related]
9. Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes.
Marini JC; Erez A; Castillo L; Lee B
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1764-71. PubMed ID: 17925451
[TBL] [Abstract][Full Text] [Related]
10. [A new family with mutation of the structural gene of human ornithine carbamoyltransferase].
Stoll C; Bieth R; Dreyfus J; Flori E; Lutz P; Levy JM
Arch Fr Pediatr; 1978 May; 35(5):512-8. PubMed ID: 678030
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation.
Ahrens MJ; Berry SA; Whitley CB; Markowitz DJ; Plante RJ; Tuchman M
Am J Med Genet; 1996 Dec; 66(3):311-5. PubMed ID: 8985493
[TBL] [Abstract][Full Text] [Related]
12. Development and inducibility of the hepatic and renal hippurate-synthesizing system in sparse-fur (spf) mutant mice with ornithine transcarbamylase deficiency.
Qureshi IA; Lebel S; Letarte J
Biochem Int; 1989 Sep; 19(3):657-66. PubMed ID: 2818615
[TBL] [Abstract][Full Text] [Related]
13. The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency.
Batshaw ML; Yudkoff M; McLaughlin BA; Gorry E; Anegawa NJ; Smith IA; Hyman SL; Robinson MB
Gene Ther; 1995 Dec; 2(10):743-9. PubMed ID: 8750014
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of patients with late onset ornithine transcarbamylase deficiency.
Tuchman M; Holzknecht RA
Clin Invest Med; 1991 Aug; 14(4):320-4. PubMed ID: 1782729
[TBL] [Abstract][Full Text] [Related]
15. The role of hepatic ornithine transcarbamylase deficiency in the orotic aciduria of pregnant mice.
Qureshi IA; Letarte J; Tuchweber B; Yousef I; Qureshi SR
Eur J Obstet Gynecol Reprod Biol; 1986 Jul; 22(3):183-91. PubMed ID: 3732588
[TBL] [Abstract][Full Text] [Related]
16. Significance of transported glycine in the conjugation of sodium benzoate in spf mutant mice with ornithine transcarbamylase deficiency.
Qureshi I; Rouleau T; Letarte J; Ouellet R
Biochem Int; 1986 Jun; 12(6):839-46. PubMed ID: 3091026
[TBL] [Abstract][Full Text] [Related]
17. Immunochemical analysis of carbamyl phosphate synthetase I and ornithine transcarbamylase deficient livers: elevated N-acetylglutamate level in a liver lacking carbamyl phosphate synthetase protein.
Zhang W; Holzknecht RA; Butkowski RJ; Tuchman M
Clin Invest Med; 1990 Aug; 13(4):183-8. PubMed ID: 2208834
[TBL] [Abstract][Full Text] [Related]
18. Normalization of hair growth in sparse fur-abnormal skin and hair (SPF-ASH) mice by introduction of the rat ornithine transcarbamylase (OTC) gene.
Shimada T; Tashiro M; Kanzaki T; Noda T; Murakami T; Takiguchi M; Mori M; Yamamura K; Saheki T
J Dermatol Sci; 1994 Jul; 7 Suppl():S27-32. PubMed ID: 7999674
[TBL] [Abstract][Full Text] [Related]
19. Ornithine transcarbamylase deficiency in mutant mice I. Studies on the characterization of enzyme defect and suitability as animal model of human disease.
Qureshi IA; Letarte J; Ouellet R
Pediatr Res; 1979 Jul; 13(7):807-11. PubMed ID: 481951
[No Abstract] [Full Text] [Related]
20. Successful living-donor liver transplantation from an asymptomatic carrier mother in ornithine transcarbamylase deficiency.
Nagasaka H; Yorifuji T; Egawa H; Kikuta H; Tanaka K; Kobayashi K
J Pediatr; 2001 Mar; 138(3):432-4. PubMed ID: 11241058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
